News Summary

Max Hodak, former president of Neuralink, has launched a new division within his startup, Science Corporation, focusing on organ preservation. The company, based in Alameda, California, aims to improve perfusion systems that keep organs viable for transplants by making them more portable and cost-efficient. This initiative is part of Science’s broader focus on longevity technologies, which also includes neural interfaces and vision restoration. Science acquired a retinal implant technology from French startup Pixium Vision in 2024, which is being commercialized to aid those with advanced macular degeneration. Hodak was inspired to explore organ preservation after learning about a case involving a 17-year-old cystic fibrosis patient who died while awaiting a lung transplant. The company has raised approximately $290 million since its inception.